Randomized Phase II/III Study of DA-EPOCH-R +/- Venetoclax in Previously Untreated Double Hit Lymphoma: Initial Results from Alliance A051701
      Google Scholar   
Citation:
Blood vol 138 (Supplement 1) 523
Meeting Instance:
ASH 2021
Year:
2021
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Primary
Analysis:
Preliminary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882; U10CA180820 and UG1CA232760 (ECOG-ACRIN)  
Corr. Author:
 
Authors:
                           
Networks:
ADM403, ALLIANCE, KANSAS, LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-WI020, MD001, NC002, NY018, OR013, PA075, PA121   
Study
A051701
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2/3
Keywords: